Cargando…
Clinical verification of body mass index and tumor immune response in patients with breast cancer receiving preoperative chemotherapy
PURPOSE: The body mass index (BMI) is commonly used as a simple indicator of obesity; patients with early-stage breast cancer who are obese (OB) per BMI measurements have been shown to have high postoperative recurrence and low survival rates. On the other hand, it has been shown that lymphocytes pr...
Autores principales: | Takada, Koji, Kashiwagi, Shinichiro, Asano, Yuka, Goto, Wataru, Ishihara, Sae, Morisaki, Tamami, Shibutani, Masatsune, Tanaka, Hiroaki, Hirakawa, Kosei, Ohira, Masaichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529767/ https://www.ncbi.nlm.nih.gov/pubmed/34670511 http://dx.doi.org/10.1186/s12885-021-08857-7 |
Ejemplares similares
-
Prediction of survival after eribulin chemotherapy for breast cancer by absolute lymphocyte counts and progression types
por: Morisaki, Tamami, et al.
Publicado: (2021) -
Differences in tumor-infiltrating lymphocyte density and prognostic factors for breast cancer by patient age
por: Takada, Koji, et al.
Publicado: (2022) -
Prediction of distant metastatic recurrence by tumor-infiltrating lymphocytes in hormone receptor-positive breast cancer
por: Takada, Koji, et al.
Publicado: (2021) -
Prediction of lymph node metastasis by tumor-infiltrating lymphocytes in T1 breast cancer
por: Takada, Koji, et al.
Publicado: (2020) -
The effect of smoking on biological change of recurrent breast cancer
por: Takada, Koji, et al.
Publicado: (2020)